课题基金 / 基金详情

Analysis of redox system regulating the expression of HIF-lα in squamous cell carcinomas

Analysis of redox system regulating the expression of HIF-lα in squamous cell carcinomas
鳞状细胞癌中氧化还原系统调控HIF-lα表达的分析
批准号:
18390544
负责人:
YAMAMOTO Tetsuya
金额:
$11.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

YAMAMOTO Tetsuya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We analyzed the mechanism how endogenous ROS induced HIF-lα expression on both mRNA and protein levels under normoxic and hypoxic conditions by using oral squamous cell carcinoma cell lines transfected with manganese-superoxide dismutase siRNA (SI cells) and scrambled control siRNA (mock cells). The results are as follows.1. The interaction between HIF-lα and pVHL proteins and the following ubiquitination of HIF-lα protein were suppressed in SI cells as compared with mock cells. However, significant differences on both mRNA and protein levels of PHD 1-3 expression were not observed.2. The phosphorylation of ERK and Akt was induced in SI cells under both normoxic and hypoxic conditions and these effects were suppressed by treatment with ERK inhibitor (PD98059) and Akt inhibitor (LY294002).3. The phosphorylation levels of p70S6K, elF-4E and 4E-BP1, which are located downstream of ERK and Akt and regulate the translation of HIF-la, were also more increased in SI cells as compared with mock cells. These effects were strongly suppressed by treatment with PD98059 and LY294002.4. Although mRNA level and promoter activity of HIF-lα was not influenced by both inhibitors in mock cells, the obvious suppressive effect was observed in SI cells, especially under normoxic conditions.5. Although the expression of HIF-lα protein was completely suppressed by ERK and Akt inhibitors under normoxic conditions, only PD98059 suppressed the HIF-lα expression under hypoxic conditions.These results suggest that endogenous ROS regulate the expression of HIF-lα through the two mechanisms; (1) the inhibition of the interaction between HIF-lα and pVHL, the following ubiquitination and degradation of HIF-lα protein and (2) the promotion of the transcription and translation of HIF-lα by the activation of ERK and Akt signal pathways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2007
期刊: Int J Cancer 120
影响因子: --
作者: [Oshikawa T, Okamoto M, Tano T, Sasai A, Kan S, Moriya Y, Ryoma Y, Saito M, Akira S, Sato M, 山下 秀一郎, Hibi H, Sasabe E]
通讯作者: Sasabe E
Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1.
紧密连接蛋白claudin-1通过基质金属蛋白酶(MMP)-2和膜型MMP-1促进层粘连蛋白-5γ2链的裂解,从而增强口腔鳞状细胞癌细胞的侵袭活性。
DOI: --
发表时间: 2006
期刊: Cancer Research 66(10)
影响因子: --
作者: [Oku N, Sasabe E, Ueta E, Yamamoto T, Osaki T]
通讯作者: Osaki T
口腔扁平上皮癌細胞のHypoxia-inducible factor-1α発現に及ぼす細胞内活性酸素の影響
细胞内活性氧对口腔鳞癌细胞缺氧诱导因子1α表达的影响
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [笹部 衣里, 大野 清二, 植田 栄作, 山本 哲也]
通讯作者: 山本 哲也
DOI: --
发表时间: 2006
期刊: Oral Oncology 42
影响因子: --
作者: [Yamamoto T, Oku N, Tatemoto Y, Ueta E, Kamatani T, Sasabe E, Osaki T]
通讯作者: Osaki T
17
    Establishment of a novel therapy for glioblastoma with Alternative Magnetic Fields
    • 批准号:
      20K09396
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2020
    • 负责人:
      YAMAMOTO Tetsuya
    • 依托单位:
    Development of neurocognitive interventions for prevention of relapse/recurrence in major depressive disorder
    • 批准号:
      18K13323
    • 项目类别:
      Grant-in-Aid for Early-Career Scientists
    • 资助金额:
      $2.66万
    • 财政年份:
      2018
    • 负责人:
      YAMAMOTO Tetsuya
    • 依托单位:
    Amino Acid Pre-loading for Boron Neutron Capture Therapy
    • 批准号:
      26462198
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2014
    • 负责人:
      YAMAMOTO Tetsuya
    • 依托单位:
    Quantitative nondestructive evaluation using ultrasonic wave visualization technique for structural health monitoring
    海外基金